JOSE VIDAL: Open Payments
NPI 1477546075 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 11 payments from 6 companies in 2025. Trend: 2023 $898 · 2024 $434 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $266 |
| Abbott Laboratories | 1 | $129 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| Alkermes, Inc. | 1 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
Products named: COBENFY, TACTICATH ABLATION CATHETER, SENSOR ENABLED, UZEDY, ABILIFY ASIMTUFII, LYBALVI, CAPLYTA.
Industry payments across TX — which companies pay providers there.
